CLINICAL RESEARCH SOLUTIONS SL
Company details
- Defunct NIF/CIF: B72188907
-
-
-
-
Address: C/ ALVAR NUÑEZ 2 Bl7 4º C (PUERTO DE SANTA MARIA (EL))
-
-
Featured products:
More information on CLINICAL RESEARCH SOLUTIONS SL
-
12/06/2019 | BORME act no.: 251344 | Register: CÁDIZCierre provisional hoja registral por baja en el índice de Entidades Jurídicas
-
31/10/2013 | BORME act no.: 465564 | Register: CÁDIZCeses/Dimisiones
-
31/10/2013 | BORME act no.: 465564 | Register: CÁDIZNombramientos
-
31/10/2013 | BORME act no.: 465564 | Register: CÁDIZDisolución
-
27/05/2011 | BORME act no.: 227458 | Register: CÁDIZConstitución
-
27/05/2011 | BORME act no.: 227458 | Register: CÁDIZNombramientos
Other information
The CIF assigned to CLINICAL RESEARCH SOLUTIONS SL is B72188907, and its commercial status is defunct. The company is engaged in economic activities classified under the CNAE 72 - Investigación y desarrollo. Additionally, it is categorized with the SIC code 8731 - Investigación física comercial.
CLINICAL RESEARCH SOLUTIONS SL employs approximately Between 10 and 49 employees and records an annual turnover of less than 2 million euros. The company is registered in the Commercial Registry of Cádiz, and has 2 registration charges. The most recent announcement in Borme was published on 12/06/2019, while the last deposit of ordinary annual accounts corresponds to the year -.
To find out the contact information of CLINICAL RESEARCH SOLUTIONS SL, such as the telephone number, postal address, or website, you can access the Company Data module.
If you wish to obtain additional information about CLINICAL RESEARCH SOLUTIONS SL, we invite you to consult any of the available financial reports, the Annual Accounts of the company, or review the incidents of defaults registered in the RAI delinquency file.
The financial, commercial, and legal information about CLINICAL RESEARCH SOLUTIONS SL comes from official data sources and is automatically updated every day.
Do you want to know more about CLINICAL RESEARCH SOLUTIONS SL??
Find out more about this company by consulting these reports: